William Collier

Direktor/Vorstandsmitglied bei Genevant Sciences Corp.

Vermögen: - $ am 30.04.2024

64 Jahre

Health Technology

Consumer Services

Aktive Positionen von William Collier

Unternehmen	Position	Beginn	Ende
Genevant Sciences Corp. Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.	Direktor/Vorstandsmitglied	-	-

Karriereverlauf von William Collier

Ehemalige bekannte Positionen von William Collier

Unternehmen	Position	Beginn	Ende
ARBUTUS BIOPHARMA CORPORATION	Direktor/Vorstandsmitglied	24.06.2019	31.12.2023
	Vorstandsvorsitzender	24.06.2019	31.12.2023
	Investor Relations Kontakt	24.06.2019	21.09.2021
	Public Communications Contact	24.06.2019	-
	Präsident	24.06.2019	31.12.2023
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA.	Vorstandsvorsitzender	-	31.12.2023
	Präsident	-	31.12.2023
International Partnership for Microbicides International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD.	Direktor/Vorstandsmitglied	01.01.2018	01.01.2021
Aids United	Direktor/Vorstandsmitglied	01.01.2011	01.01.2018
Glaxowellcom	Corporate Officer/Principal	-	-
ViiV Healthcare Ltd. ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.	Präsident	-	-

Ausbildung von William Collier

University of Manchester Institute of Science & Technology

Undergraduate Degree

Statistik

International

Vereinigte Staaten	6
Vereinigtes Königreich	3
Kanada	2

Operativ

Director/Board Member	4
President	3
Chief Executive Officer	2

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	1
ARBUTUS BIOPHARMA CORPORATION	Health Technology

Private Unternehmen	6
ViiV Healthcare Ltd. ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.	Health Technology
Genevant Sciences Corp. Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.	Health Technology
International Partnership for Microbicides International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD.	Health Technology
Aids United
Glaxowellcom
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an